We are live on ! Find out more
SBBP

Strongbridge Biopharma plc.
SBBP

Delisted

SBBP was delisted on the 5th of October, 2021.

Back to rankings

15 hedge funds and large institutions have $40M invested in Strongbridge Biopharma plc. in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

6% less funds holding

Funds holding: 16 → 15 (-1)

40% less capital invested

Capital invested by funds: $66.4M → $40M (-$26.4M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$382K
2
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$4.61K
3
UBS Group
UBS Group
Switzerland
+$207
4
Citigroup
Citigroup
New York
+$23

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$546K
2
BIT
BlackRock Institutional Trust
California
-$47K
3
TRCT
Tower Research Capital (TRC)
New York
-$8K
4
BA
BlackRock Advisors
Delaware
-$3.75K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$12.3M – – –
NMC
2
NEA Management Company
Maryland
$9.76M – – –
BC
3
Broadfin Capital
New York
$7.55M – – –
TAF
4
Tredje AP-fonden
Sweden
$5.07M – – –
ACP
5
Acuta Capital Partners
California
$4.51M +$382K +84,840 +9%
GTC
6
Ghost Tree Capital
New York
$332K – – –
SFM
7
Sphera Funds Management
Israel
$277K -$546K -121,100 -67%
BA
8
BlackRock Advisors
Delaware
$152K -$3.75K -833 -2%
Bank of America
9
Bank of America
North Carolina
$14K – – –
UBS Group
10
UBS Group
Switzerland
$14K +$207 +46 +2%
BJ
11
BlackRock Japan
Japan
$8K – – –
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$6K – – –
BIM
13
BlackRock Investment Management
Delaware
$6K – – –
Manulife (Manufacturers Life Insurance)
14
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5K +$4.61K +1,022 New
BIT
15
BlackRock Institutional Trust
California
– -$47K -6,147 Closed
TRCT
16
Tower Research Capital (TRC)
New York
– -$8K -1,094 Closed
Citigroup
17
Citigroup
New York
– +$23 +5 New

SBBP Hedge Fund Activity: Q1 2016 in Review

15 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q1 2016, worth a combined $40M — down 40% from $66.4M a quarter earlier.

Fund positioning in SBBP was balanced in Q1 2016: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was Acuta Capital Partners, adding an estimated $382K. The largest seller was Sphera Funds Management, cutting an estimated $546K.

  • 15 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q1 2016, down from 16 in Q4 2015.
  • Funds reported $40M of Strongbridge Biopharma plc. stock for Q1 2016, down 40% quarter-over-quarter.
  • 2 funds opened new Strongbridge Biopharma plc. positions in Q1 2016 and 2 closed out, a net change of 0 holders.
  • The largest Strongbridge Biopharma plc. buyer in Q1 2016 was Acuta Capital Partners, an estimated $382K added.
  • The largest Strongbridge Biopharma plc. seller in Q1 2016 was Sphera Funds Management, an estimated $546K sold.

Based on aggregated 13F filings for Q1 2016.